1,625
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Identification of FCER1G as a key gene in multiple myeloma based on weighted gene co-expression network analysis

ORCID Icon, , , , , & show all
Article: 2210904 | Received 07 Jun 2022, Accepted 02 May 2023, Published online: 12 May 2023

References

  • Cowan AJ, Green DJ, Kwok M, et al. Diagnosis and management of multiple myeloma: A Review. Jama. 2022;327(5):464–477.
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
  • van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397(10272):410–427.
  • Kumar SK, Dimopoulos MA, Kastritis E, et al. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study. Leukemia. 2017;31(11):2443–2448.
  • Zhou L, Yu Q, Wei G, et al. Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019. BMC Cancer. 2021;21(1):606.
  • Martinez-Lopez J, Blade J, Mateos M-V, et al. Long-term prognostic significance of response in multiple myeloma after stem cell transplantation. Blood. 2011;118(3):529–534.
  • Marinac CR, Ghobrial IM, Birmann BM, et al. Dissecting racial disparities in multiple myeloma. Blood Cancer J. 2020;10(2):19.
  • Choi JK, Yu U, Yoo OJ, et al. Differential coexpression analysis using microarray data and its application to human cancer. Bioinformatics. 2005;21(24):4348–4355.
  • Ban C, Yang F, Wei M, et al. Integrative analysis of gene expression through one-class logistic regression machine learning identifies stemness features in multiple myeloma. Front Genet. 2021;12:666561.
  • Wang R, Bu W, Yang Y. Identification of metabolism-related genes influencing prognosis of multiple myeloma patients. J Healthc Eng. 2021;2021:6574491.
  • Wu D, Miao J, Hu J, et al. Psmb7 Is a Key gene involved in the development of multiple myeloma and resistance to bortezomib. Front Oncol. 2021;11:684232.
  • Xu M, Meng Y, Li Q, et al. Identification of biomarkers for early diagnosis of multiple myeloma by weighted gene co-expression network analysis and their clinical relevance. Hematology. 2022;27(1):322–331.
  • Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):559.
  • Chauhan D, Tian Z, Nicholson B, et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell. 2012;22(3):345–358.
  • Agnelli L, Mosca L, Fabris S, et al. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect. Genes Chromosomes Cancer. 2009;48(7):603–614.
  • Hanamura I, Huang Y, Zhan F, et al. Prognostic value of Cyclin D2 mRNA expression in newly diagnosed multiple myeloma treated with high-dose chemotherapy and tandem autologous stem cell transplantations. Leukemia. 2006;20(7):1288–1290.
  • Gautier L, Cope L, Bolstad BM, et al. Affy—analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307–315.
  • Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
  • Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article17.
  • Botía JA, Vandrovcova J, Forabosco P, et al. An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks. BMC Syst Biol. 2017;11(1):47.
  • Yip AM, Horvath S. Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinformatics. 2007;8:22.
  • Ravasz E, Somera AL, Mongru DA, et al. Hierarchical organization of modularity in metabolic networks. Science. 2002;297(5586):1551–1555.
  • Presson AP, Sobel EM, Papp JC, et al. Integrated weighted gene Co-expression network analysis with an application to chronic fatigue syndrome. BMC Syst Biol. 2008;2:95.
  • Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447–D452.
  • Kishore J, Goel M, Khanna P. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2010;1(4):274–278.
  • Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61(1):92–105.
  • Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.
  • Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
  • Weiss BM, Abadie J, Verma P, et al. A monoclonal gammopathy precedes multiple myeloma in most patients. Blood. 2009;113(22):5418–5422.
  • Long J, Huang S, Bai Y, et al. Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis. Brief Bioinform. 2021;22(4):bbaa224.
  • Su R, Jin C, Zhou L, et al. Construction of a ceRNA network of hub genes affecting immune infiltration in ovarian cancer identified by WGCNA. BMC Cancer. 2021;21(1):970.
  • You J-A, Gong Y, Wu Y, et al. Wgcna, LASSO and SVM algorithm revealed RAC1 correlated M0 macrophage and the risk score to predict the survival of hepatocellular carcinoma patients. Front Genet. 2022;12:730920.
  • Rezaei Z, Ranjbaran J, Safarpour H, et al. Identification of early diagnostic biomarkers via WGCNA in gastric cancer. Biomed Pharmacother. 2022;145:112477.
  • Liu H, Liu M, You H, et al. Oncogenic network and Hub genes for natural killer/T-cell lymphoma utilizing WGCNA. Front Oncol. 2020;10:223.
  • Guo D, Wang H, Sun L, et al. Identification of key gene modules and hub genes of human mantle cell lymphoma by coexpression network analysis. PeerJ. 2020;8:e8843.
  • Haase F, Gloss BS, Tam PPL, et al. Wgcna identifies translational and proteasome-ubiquitin dysfunction in rett syndrome. Int J Mol Sci. 2021;22(18):9954.
  • Yao M, Zhang C, Gao C, et al. Exploration of the shared gene signatures and molecular mechanisms between systemic lupus erythematosus and pulmonary arterial hypertension: evidence from transcriptome data. Front Immunol. 2021;12:658341.
  • Wang Y, Chen G, Shao W. Identification of ferroptosis-related genes in Alzheimer’s disease based on bioinformatic analysis. Front Neurosci. 2022;16:823741.
  • Wang J, Yin Y, Lu Q, et al. Identification of important modules and Hub gene in chronic kidney disease based on WGCNA. J Immunol Res. 2022;2022:4615292.
  • Chen X, He X-Y, Dan Q, et al. FAM201A, a long noncoding RNA potentially associated with atrial fibrillation identified by ceRNA network analyses and WGCNA. BMC Med Genomics. 2022;15(1):80.
  • Zhang L, Sun S, Wang Y, et al. Gossypol induces apoptosis of multiple myeloma cells through the JUN-JNK pathway. Am J Cancer Res. 2020;10(3):870–883.
  • Hu F, Chen X-Q, Li X-P, et al. Drug resistance biomarker ABCC4 of selinexor and immune feature in multiple myeloma. Int Immunopharmacol. 2022;108:108722.
  • Liu L, Qu J, Dai Y, et al. An interactive nomogram based on clinical and molecular signatures to predict prognosis in multiple myeloma patients. Aging. 2021;13(14):18442–18463.
  • Küster H, Thompson H, Kinet JP. Characterization and expression of the gene for the human Fc receptor gamma subunit. Definition of a new gene family. J Biol Chem. 1990;265(11):6448–6452.
  • Brandsma AM, Hogarth PM, Nimmerjahn F, et al. Clarifying the confusion between cytokine and Fc receptor “common gamma chain”. Immunity. 2016;45(2):225–226.
  • Xu H, Zhu Q, Tang L, et al. Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy. Cancer Cell Int. 2021;21(1):103.
  • Liu S, Wang C, Yang H, et al. Weighted gene co-expression network analysis identifies FCER1G as a key gene associated with diabetic kidney disease. Ann Transl Med. 2020;8(21):1427.
  • Chen Q, Wang S, Lang J-H. Development and validation of nomogram with tumor microenvironment-related genes and clinical factors for predicting overall survival of endometrial cancer. J Cancer. 2021;12(12):3530–3538.
  • Li J, Shi H, Yuan Z, et al. The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration. BMC Cancer. 2022;22(1):108.
  • A Self-reactive Innate-like T-cell Program Was Identified in Cancer Immunity. Cancer Discov. 2022. OF1. Online Ahead of Print.
  • Zou M, Su X, Wang L, et al. The molecular mechanism of multiple organ dysfunction and targeted intervention of COVID-19 based on time-order transcriptomic analysis. Front Immunol. 2021;12:729776.
  • Dong K, Chen W, Pan X, et al. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity. BMC Cancer. 2022;22(1):140.
  • Selin L, Duhan V, Hamdan TA, et al. NK cell–intrinsic FcϵRIγ limits CD8+ T-cell expansion and thereby turns an acute into a chronic viral infection. PLoS Pathog. 2019;15(6):e1007797.
  • Fu L, Cheng Z, Dong F, et al. Enhanced expression of FCER1G predicts positive prognosis in multiple myeloma. J Cancer. 2020;11(5):1182–1194.
  • Yang Q, Li K, Li X, et al. Identification of key genes and pathways in myeloma side population cells by bioinformatics analysis. Int J Med Sci. 2020;17(14):2063–2076.